Wendy Galpern

2002-2003 Neurology Harvard Medical School, Boston, MA, United States 
"Wendy Galpern"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Becker S, Granert O, Timmers M, et al. (2020) Association of hippocampal subfields, CSF biomarkers and cognition in non-demented Parkinson's disease patients. Neurology
Van Kolen K, Malia TJ, Theunis C, et al. (2020) Discovery and Functional Characterization of hPT3, a Humanized Anti-Phospho Tau Selective Monoclonal Antibody. Journal of Alzheimer's Disease : Jad
Triana-Baltzer G, Van Kolen K, Theunis C, et al. (2020) Development and Validation of a High Sensitivity Assay for Measuring p217 + tau in Cerebrospinal Fluid. Journal of Alzheimer's Disease : Jad
Walsh RR, Krismer F, Galpern WR, et al. (2017) Recommendations of the Global Multiple System Atrophy Research Roadmap Meeting. Neurology
Hopfner F, Haubenberger D, Galpern WR, et al. (2016) Knowledge gaps and research recommendations for essential tremor. Parkinsonism & Related Disorders
Comella CL, Perlmutter JS, Jinnah HA, et al. (2016) Clinimetric testing of the comprehensive cervical dystonia rating scale. Movement Disorders : Official Journal of the Movement Disorder Society
Comella CL, Fox SH, Bhatia KP, et al. (2015) Development of the Comprehensive Cervical Dystonia Rating Scale: Methodology. Movement Disorders Clinical Practice. 2: 135-141
Jinnah HA, Teller JK, Galpern WR. (2015) Recent developments in dystonia. Current Opinion in Neurology. 28: 400-5
Yan L, Hicks M, Winslow K, et al. (2015) Secured web-based video repository for multicenter studies. Parkinsonism & Related Disorders. 21: 366-71
Cedarbaum JM, Stephenson D, Rudick R, et al. (2015) Erratum to: Commonalities and Challenges in the Development of Clinical Trial Measures in Neurology. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 12: 285
See more...